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Abstract
Introduction
Somatic symptoms are frequently reported by children with significant impairment in func-
tioning. Despite studies on adult populations that suggest somatic symptoms often co-occur
with difficulties in identifying and describing feelings, little research has been done in child-
hood. This study aimed to investigate the prevalence and frequency of somatic symptoms
as well as to investigate the functional impairment in children with high number of self
reported somatic symptoms versus those with fewer somatic symptoms. Additionally the
parental perception of their children’s somatic symptoms and functioning was explored.
Finally, we explored the direct and indirect effects of difficulties in identifying feelings in pre-
dicting somatic symptoms and functional disability among school-aged children.
Methods
356 Italian school-aged children and their mothers participated in this study. Children (mean
age = 11.43; SD = 2.41) completed the Children’s Somatization Inventory (CSI-24) to
assess somatic symptoms, the Functional Disability Inventory (FDI) to assess physical and
psychosocial functioning and the Alexithymia Questionnaire for Children (AQC) to evaluate
alexithymic features. Mothers completed the parental forms of the CSI and the FDI.
Results
Among children, 66.3% did not declare somatic symptoms and 33.7% reported one or more
somatic symptoms in the last two weeks. A significant positive correlation emerged between
children’s and mothers’ CSI total scores. Both children’s and mothers’ FDI total scores were
significantly correlated with CSI scores. A significant correlation was observed between
somatic symptoms and alexithymic features. Furthermore, the data showed that somatic
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symptoms mediated the relationship between difficulties in identifying feelings and func-
tional impairment. Finally, it was showed that alexithymia facet of difficulty in identifying feel-
ings contributed in large part to the prediction of the somatic symptomatology (b = 0.978, p <
0.001; R2 = 0.164, F(5, 350) = 10.32, p < 0.001).
Conclusions
Findings from this study provide evidence that a higher frequency of somatic symptoms is
associated with functional disabilities and alexithymic facets in school-aged children.
Introduction
For a long time, children presenting physical symptoms without a clear medical cause, some-
times defined as medically unexplained symptoms or functional somatic symptoms, have been
commonly recognized as relevant and problematic aspects of paediatric practice among clini-
cal and non-clinical settings [1]. Both definitions appeared relatively neutral, properly descrip-
tive, non-pejorative, and generally accepted by various medical specialities [2,3], but, in the
recent years, they have been debated in light of the proposed criteria for the fifth version of the
Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and included in the new cate-
gory of “Somatic Symptom and Other Related Disorders” [4]. These disorders are character-
ized by somatic symptoms (SS) causing significant distress or dysfunction and they include
psychosocial factors that may be considered as symptom initiating, aggravating and perpetuat-
ing factors [4,5].
According to the DSM-5, individuals may have a combination of physical symptoms for
which an organic cause can be found and symptoms for which there is no underlying medical
explanation. SS must be significantly distressing or disruptive to daily life and must be accom-
panied by excessive thoughts, feelings, or behaviours [4]. These new criteria seem to be more
in line with findings from previous studies on developmental age. However, several general
limitations of a categorical approach should be considered when the focus is on a paediatric
population, since SS are subjective experiences and children may have difficulty in describing
the presence, concern and levels of severity of the disease. More emphasis should be laid on
the relationship between child and environment, as well as the child’s adaptive functioning.
The effective communication between the main caregivers of the child and the child him/her-
self is necessary for successful management of somatic symptoms [3].
In childhood and adolescence, physical symptoms accompanied by emotional distress rep-
resent a complex and multi-determined phenomenon to deal with in clinical practice and they
can lead to considerable impairment in a child’s life, influencing development, school atten-
dance and achievement as well as social adjustment [1].
SS are common in school-aged children, with approximately 25% of children experiencing
chronic or recurrent pain (e.g., headache, abdominal pain, and sore muscles) and 10% report-
ing chronic fatigue [6–8]. For some children, these symptoms are short-lived with no negative
long-term impact on daily functioning or developmental course. However, the majority of
these symptoms are associated with functional disability, emotional distress, requests for medi-
cal care and school absenteeism [5,9,10] as well as fewer hobbies, impairment in daily life, lei-
sure and sporting activities [11].
To date, the contributions devoted to identifying the risk factors that influence the trajecto-
ries of SS and the outcomes of maladaptive child behaviour have been poorly assessed.
Somatic symptoms and psychoemotional functioning in children
PLOS ONE | DOI:10.1371/journal.pone.0171867 February 8, 2017 2 / 11
Research has demonstrated a strong correlation between SS and alexithymia, even if most
studies have been conducted on adult samples [12], in which a greater difficulty in identifying
feelings appeared in conjunction with SS [13,14]. Alexithymia refers to a limited ability to
identify and communicate one’ s feelings, which has been frequently associated with physical
health complaints [15,16]. Alexithymia is also an important risk factor for the onset of somatic
symptoms in children, even though few studies have focused on non-clinical populations [8].
Nemzer [17] highlighted that the lack of cognitive capacity and adequate emotion regulation
skills may lead to SS in specific situations with a negative impact on academic and psychosocial
functioning.
According to a developmental perspective and with research indicating the importance of
social contest, the particular care of parents may reinforce the expression of SS [18]. Previous
research [19–22] has illustrated that the correspondence between children and parents was
rather modest in the case of children’s SS. More precisely, parents typically indicated fewer SS
than do their children in school-based children samples [22]. Conversely, parents are likely
to report more SS compared with children among clinical samples [23]..Moreover, studies
pointed out that parents who are more supportive and sensitive may facilitate their children in
successfully managing distress and coping with emotionally arousing situations [24].
In light of the above considerations, our principle aims were to:
1. determine the prevalence and frequency of somatic symptoms reported by children;
2. investigate whether there is a functional impairment in children with a high number of self-
reported SS compared to those who report fewer SS;
3. analyze the parental perceptions of their children’s somatic symptoms, since health beliefs
and family rules are passed on to children by their parents or other significant family
members,
4. explore the relationship between SS and alexithymic features;
5. verify the hypothesis that difficulties in identifying feelings (DIF) is not only predictive of
multiple SS but also of functional impairment, with an indirect effect through SS on func-
tional impairment.
Consistent with previous research, we hypothesized that school-aged children with a high
number of SS present higher levels of alexithymic features than healthy youth. Furthermore,
we expected that alexithymic features predicted the risk to experience multiple SS and related
functional impairment.
Materials and methods
Participants
Three hundred and fifty-six Italian children, 176 girls (49.4%) and 180 boys (50.6%) aged 8 to
15 years (mean age = 11.43; SD = 2.41), and their mothers (n = 356) were recruited for this
study (Table 1). All participants were Caucasian. Mothers were asked about the health status of
their children in a specific schedule. Children undergoing pharmacological therapy (n = 10;
2.6%), or having existing diagnosed infections or other medical illnesses (n = 22; 5.6%) or
undergoing psychological therapy (n = 1; 0.2%) were excluded from the final sample. The sam-
ple of participants were part of a general non-clinical population and were recruited in pri-
mary and middle public schools in central Italy and involved in the study as part of a health
promotion project. A written informed consent was obtained from the parents before inclu-
sion in this study. Collective administration of the self-report questionnaires took place during
Somatic symptoms and psychoemotional functioning in children
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school time in the classrooms. Mothers received the questionnaires via their children, with the
request to complete measures at home and return materials in a sealed envelope. Anonymity
of participants was ensured. This study was approved by the Ethics Committee of the Medicine
and Psychology Faculty, Sapienza University of Rome.
Measures
Assessment schedule of children’s health. Mothers were asked to report upon their
child’s physical and mental health status by completing a specific list of medical illnesses and/
or existing diagnoses, as well as report if their child was under pharmacological and/or psycho-
logical therapy.
Somatic symptoms. The Children’s Somatization Inventory (CSI) [25,26] was used to
assess children’s perception of SS. Specifically, the short version of the CSI (CSI-24) [27] was
translated into Italian using the translation–back-translation method, with the approval of the
Author. This instrument explores the presence of SS but is most commonly used to assess
somatization among children and adolescents [2,28]. The CSI-24 score was computed follow-
ing instructions given in Appendix I by Walker and colleagues [27]. Besides to give the reader
a screenshot of the distribution of SS, we further considered the score obtained from the sum
of the dichotomized CSI items as described in Walker, Garber and Greene [25]. Adequate reli-
ability and validity of the CSI has been established. In healthy paediatric samples, internal con-
sistency (i.e., Cronbach’s alpha) of the CSI-24 was .87 [27]. In the current study, Cronbach’s
coefficient was .84. The Children’s Somatization Inventory-Parent Form (CSI-P) is identical to
the child form (CSI-C), except that parents complete the questions with regard to their chil-
dren’s SS during the past 2 weeks using the same response format as the child version. The
CSI-P internal consistency in this sample was .82.
Child impairment. The Functional Disability Inventory (FDI) [29] was used to assess
children’s self-reported difficulty in physical and psychosocial functioning due to their physi-
cal health. The instrument was translated into Italian with the translation–back-translation
method and approved by the Author. Functional difficulties are expressed in 15 items concern-
ing perceptions of activity limitations during the past 2 weeks, including performance of daily
activities at home, school, recreation, and social situations. The FDI has good internal consis-
tency and 3-month test-retest reliability estimates exceeding 0.60 for patients with chronic
Table 1. Distribution of socio-demographic characteristics of participants involved in the study.
n %
Gender
boys 180 50.6
girls 176 49.4
Age
8–10 y.o 134 37.6
11–14 y.o. 183 51.4
15–16 y.o. 39 11.0
Income
0–10.000 € 15 4.2
10.000–15.000 € 39 11.0
15.000–31.000 € 119 33.4
31.000–70.000 € 113 31.7
More than 70.000 € 14 3.9
Not reported 56 15.7
doi:10.1371/journal.pone.0171867.t001
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abdominal pain. In the current study, we found an internal consistency of .77. The Functional
Disability Inventory-Parent Form (FDI-P) has the same structure of items and response for-
mat as the FDI-child form (FDI-C). Alpha reliability coefficients on the FDI-P ranged from .94
to .90. In the present sample, the Alpha coefficient was .76.
Alexithymia. In order to assess alexithymic features, children completed the validated
Italian version of the Alexithymia Questionnaire for Children (AQC) [30,31]. It is a simplified
version of the Toronto Alexithymia Scale (TAS-20) [32], and this questionnaire consisted of
20 items, representing 3 factors: Difficulty Identifying Feelings (DIF); Difficulty Describing
Feelings (DDF) and Externally-Oriented Thinking (EOT). The internal consistency for the
DIF and the DDF scales was good (Cronbach’s alpha of approximately .75), while the EOT fac-
tor did not meet the criteria for internal consistency nor item homogeneity, as also confirmed
in the present study (.27). In the current study, Cronbach’s alpha was .74 for DIF and .62 for
DDF.
Statistical analyses
The SPSS 19.0 (Statistical Package for Social Sciences) software package was employed in the
analyses of the data. Descriptive statistical analysis were used to describe the characteristics of
participants. Pearson correlations were computed to determine the associations between
somatic symptoms, child impairment and alexithymic features.
Mediation analyses were conducted to examine the direct effect of the DIF on functional
disability, and its indirect effect through SS as measured by the CSI-24 on functional im-
pairment. Mediation was tested using the SPSS macro, PROCESS. In particular, a series of lin-
ear regression models were fitted, and the size and significance of the indirect effects were
estimated by a bootstrap procedure.
Results
Descriptive statistics
Considering the CSI score obtained from the sum of dichotomized items, approximately 66.3%
(n = 236) of the total youth sample did not report SS in the last two weeks. About twenty-eight
percent (n = 100) reported 1 to 3 symptoms. The remaining 5.7% (n = 20) reported 4 or more
(up to 12) symptoms according to the threshold for somatization in children proposed by Esco-
bar [2]. By dividing the sample into three groups on the basis of reported symptoms (“no symp-
toms” vs “from 1 to 3 symptoms” vs “4 or more symptoms”), no gender differences emerged
(χ2 = 1.52 df = 2, p = 0.47). Table 2 shows the differences between child and mother reports
with respect to the frequency of SS on the CSI-24. Children reported more frequent SS than
did their mothers. In fact, 92.1% (n = 328) of mothers indicated the absence of SS compared to
only 66.3% of children (n = 236) who did not report any symptoms. 7.9% of mothers (n = 28)
declared that their children suffered from 1 or more somatic symptoms. Finally, no significant
correlations emerged between both child-reported and mother-reported SS and age (respec-
tively rho = 0.063, p = 0.236; rho = 0.099, p = 0.062).
Psychological correlates. With regards to functional disability, 5.9% of the total sample
fell into the moderate range (from 13 to 29) based on the Kashikar-Zuck cut-off [33], while
only 1.1% of mothers indicated a similar range regarding their children’s disability. A statisti-
cally significant difference was found between child (M = 4.61; SD = 5.28) and parent-report
(M = 1.32; SD = 2.59) on the FDI total score (t (356) = 11.36, p<0.001). In line with past stud-
ies [29], higher scores on the FDI were reported by children who declared more SS (r = 0.534,
p< 0.01) and a similar correlation was also found when considering mothers’ reports (r =
0.459, p< 0.01). In particular, children without SS reported a lower (t(354) = 3.26, p< 0.01)
Somatic symptoms and psychoemotional functioning in children
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mean score on the FDI (M = 3.26; SD = 4.12) while children with 1 or more symptoms had a
higher FDI mean score (M = 7.27; SD = 6.24). In the same way, mothers who indicated at least
1 or more SS presented a higher (t(354) = 2.10, p = 0.04) FDI mean score (M = 4.53; SD = 4.50)
than mothers who indicated no SS (M = 1.05; SD = 2.16). Moreover, comparing the AQC scores
as a function of participants reporting no SS with those that indicated one or more SS, it was
found that the latter participants scored significantly higher on both the DIF factor (t(354) =
5.26, p< 0.01) (M = 12.72; SD = 3.15) and the DDF factor (t(354) = 2.75, p< 0.01) (M = 9.59;
SD = 2.40) with respect to the participants reporting no SS (respectively: DIF: M = 10.93;
SD = 2.99; DDF: M = 8.85; SD = 2.40). Finally, no differences emerged between the two groups
when considering the EOT factor mean scores (respectively: No symptom group M = 14.58;
SD = 2.44;1 symptom group M = 14.68; SD = 2.63). In addition, considering correlations
among the CSI-C scores and the AQC factors, we found a positive and significant correlation
with both DIF (r = 0.393, p< 0.01) and DDF (r = 0.230, p< 0.01) but not with EOT (r = 0.029,
p = 0.584). While considering CSI-P scores, only DIF correlated positively and significantly
(r = 0.194, p<0.01) while both DDF and EOT did not (respectively: r = 0.031, p = 0.554; r =
-0.003, p = 0.961). Finally, gender correlated modestly with DIF (rho = 0.160, p = 0.002) and
with EOT (rho = -0.147, p = 0.006) but not with DDF (rho = 0.061, p = 0.252), while the age
Table 2. Frequencies and percentages of the most reported CSI symptoms for Children (N = 356) and
Mothers (N = 356).
CSI a Items Children Parents
n % n %
1 Headache 26 7.3% 8 2.2%
2 Faintness or dizziness 4 1.1% 0 0.0%
3 Pain in your heart or chest 7 2.0% 0 0%
4 Low in energy 16 4.5% 4 1.1%
5 Pains lower back 18 5.1% 6 1.7%
6 Sore Muscles 16 4.5% 2 0.6%
7 Trouble breath 5 1.4% 1 0.3%
8 Hot or cold spells 14 3.9% 4 1.1%
9 Numbness or tingling 20 5.6% 1 0.3%
10 Weakness 10 2.8% 2 0.6%
11 Heavy feelings arms or legs 6 1.7% 3 0.8%
12 Nausea or upset stomach 19 5.3% 0 0%
13 Constipation 11 3.1% 5 1.4%
14 Loose BM’s or diarrhea 4 1.1% 1 0.3%
15 Pain stomach or abdomen 30 8.4% 3 0.8%
16 Heart beating fast 16 4.5% 1 0.3%
17 Difficulty swallowing 3 0.8% 1 0.3%
18 Losing voice 9 2.5% 0 0%
19 Blurred vision 8 2.2% 1 0.3%
20 Vomiting 5 1.4% 0 0%
21 Floated or gassy 14 3.9% 2 0.6%
22 Food making sick 12 3.4% 1 0.3%
23 Pains knees, elbows or joints 13 3.7% 1 0.3%
24 Pains arms or legs 6 1.7% 1 0.3%
Note.
a CSI = Children’s Somatization Inventory
doi:10.1371/journal.pone.0171867.t002
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factor reported a significant correlation with EOT (rho = -0.187, p< 0.001) but not with both
DIF (rho = 0.101, p = 0.058) and DDF (rho = 0.024, p = 0.649).
Mediational effect of CSI. The indirect effect of DIF through SS on functional disability
was tested with the PROCESS macro for SPSS. Gender, age and the other two alexithymia fac-
tors (DDF and EOT) were introduced as covariates within the model. Results showed that
the direct effect of DIF on FDI scores was positive and significant (b = 0.259, p< 0.001) when
the CSI total score was not considered in the equation. However, when the direct effect of the
CSI score is added (b = 0.326, p< 0.001), the direct effect of DIF becomes not significant
(b = 0.115, p = 0.256). Girls showed significantly lower levels of FDI (b = -1.498, p = 0.002)
than boys. Also age showed a significant negative effect (b = -0.211, p = 0.043). However, both
DDF (b = -0.046, p = 0.715) and EOT (b = 0.173, p = 0.083) have no significant effects in pre-
dicting FDI scores. In general, all predictors explained about 32.4% of the total variability in
FDI scores (F(6, 349) = 20.53, p< 0.001). The DIF scores had a positive and significant effect
in predicting the CSI score (b = 0.978, p< 0.001; R2 = 0.164, F(5, 350) = 10.32, p< 0.001).
Finally, the total indirect effect of DIF through CSI on FDI was significant (b = 0.319, Boot-
strap 95% C.I.: 0.188–0.456) (Table 3).
Discussion
It is well known from the literature that somatic symptoms are common in childhood and that
they are closely related to mental and emotional symptoms, both in the general population
and in primary care populations [34]. These symptoms are associated with a diminished qual-
ity of life and involve difficulties in psychological and social functioning [35]. Findings from
the present cross-sectional study, highlight that a great portion of children (n = 120) declared
at least one somatic symptom during the last two weeks, and providing evidence that a higher
frequency of SS is associated with higher functional impairment. This result is comparable to
Table 3. Direct and indirect effects of DIFa on functional disability.
Measure Coeff SE t P
FDIb
CSI-Cc 0.3264 0.0345 9.4512 <0.001
DIF 0.1147 0.1007 1.1385 0.2557
Sex -1.4976 0.4876 -3.0715 0.0023
Age -0.2115 0.1041 -2.0306 0.0431
DDFd -0.0457 0.1252 -.3653 0.7151
EOTe 0.1726 0.0992 1.7400 0.0827
CSI-C
DIF 0.9776 0.1900 5.1456 <0.001
Sex 1.2002 0.8960 1.3395 0.1813
Age 0.2856 0.1866 1.5309 0.1267
DDF 0.1082 0.2102 0.5147 0.6071
EOT 0.1061 0.1821 0.5830 0.5603
Note.
a DIF = Difficulty in Identifying Feelings
b FDI = Functional Disability Inventory
c CSI-C = Children’s Somatization Inventory-Child Form
dDDF = Difficulty in Describing Feelings
e EOT = Externally Oriented Thought.
doi:10.1371/journal.pone.0171867.t003
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those of a recent study involving a school-based sample of children [35], in which youths with
more SS had greater impairment in their activities at home, school and in relationships with
peers [36, 37].
The present study evaluated the degree of parent-child agreement regarding children’s SS
and functional disability, emphasizing the use of a multi-informant approach. Studies regard-
ing parent-child agreement on SS and psychosocial functioning are few and agreement differs
among clinical and non-clinical populations. Previous studies have revealed how children
who exhibit recurrent SS miss significantly more days of school than healthy children and fre-
quently give up gym and school trips, confirming higher scores on the FDI-C [38–40]. Our
findings support the relationship between SS and impaired functioning, showing a significant
correlation between CSI-C and FDI-C as well as CSI-P and FDI-P scores.
An association between child and parent scores on both the CSI and FDI was also observed.
While the correlations indicate similarities between the rank orders of scores assigned to chil-
dren by themselves and their mothers, the mean differences yield information about family
agreement. In accordance with previous studies [19,22] our data showed a discrepancy between
children and mothers in the assessment of children’s SS and functional disability, with mothers
perceiving a lower number of symptoms in respect to their children’s self-reports, as well as a
low parental awareness concerning their children’s distress and disability [19]. These results
have a clear clinical relevance because underscore the importance of considering the level of
parental awareness about SS affecting their children and the related impact on psychosocial
functioning in the planning of a comprehensive intervention to improve the physical and psy-
chological well-being of children.
Furthermore, results from the multiple regression analyses highlighted that SS made an
independent contribution to the prediction of functional impairment, playing a role in mediat-
ing the relationship between DIF and functional disability. The associations between SS, psy-
chopathology and adaptation have been widely investigated, even if little research has been
done on the relationship between alexithymia and psychosocial functioning [41]. With regard
to the presence of somatic or medical symptoms, alexithymia has been frequently observed in
association with a variety of psychopathological conditions leading to poor coping abilities
which, in turn, may lead to an impairment in psychosocial functioning [42].
Interestingly, we found that SS played a role in mediating the relationship between DIF and
daily functional disability. This result is new to the paediatric literature while the direct effect
of DIF on SS and on functional disability have already been highlighted. In fact, data from a
recent study showed DIF was associated with health-related maladaptive behaviours as well as
the use of alcohol and drugs in a sample of young healthy men [43]. DIF has also been shown
to be positively correlated with maladaptive patterns of immature defences and ineffective cop-
ing styles, both in non-clinical and psychiatric samples [43–45] and seems to be a significant
predictor of psychopathology, particularly somatization, in psychiatric patients [45], whereas
the other two facets of alexithymia, as defined by the TAS-20, showed no significant influence
on psychopathology.
The strengths of this study include the use of established and standardized assessment mea-
sures and the use of multiple informants in order to explore children’s physical and psychoso-
cial impairments that made it possible to add new knowledge to the existing literature.
However, several important limitations warrant consideration. First, our sample consisted of
self-reported healthy children, so it is not clear whether the results may be generalized to other
populations (e.g., with chronic physical illnesses or pain). This study is cross-sectional and,
consequently, the conclusions drawn should be considered with caution. Finally, participants’
understanding of the exact definitions of the symptoms along with the unknown IQ level of
children (that is known to be linked to higher alexithymia scores) may have affected their
Somatic symptoms and psychoemotional functioning in children
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answers. In particular, it cannot be excluded that lower IQ may have affected the indirect effect
of DIF on functional scores through somatic symptoms.
Conclusion
In summary, more knowledge regarding the association between SS, functional impairment
and alexithymia in children may aid in the early identification and prevention of diverse nega-
tive developmental experiences and functional limitations which adversely affect school atten-
dance and promote the development of unhealthy social relationships. The current study
provides further support for the hypothesis suggesting a link between alexithymic facets, SS
and psychosocial functioning in children. Future research clarifying the relationship between
alexithymia and SS among young people both in clinical and non-clinical populations is
needed.
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